Perspective Therapeutics (CATX) EBITDA Margin (QoQ) (2010 - 2023)
Perspective Therapeutics (CATX) EBITDA Margin (QoQ) (2010 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 68,441.00 |
| Sep 30, 2023 | 20,404.00 |
| Jun 30, 2023 | -17,712.00 |
| Sep 30, 2022 | -4,352.00 |
| Jun 30, 2022 | -1,702.00 |
| Mar 31, 2022 | 1,078.00 |
| Dec 31, 2021 | 3,063.00 |
| Sep 30, 2021 | -13,836.00 |
| Jun 30, 2021 | 7,913.00 |
| Mar 31, 2021 | 755.00 |
| Dec 31, 2020 | -706.00 |
| Sep 30, 2020 | 2,222.00 |
| Jun 30, 2020 | -3,314.00 |
| Mar 31, 2020 | 2,191.00 |
| Dec 31, 2019 | -482.00 |
| Sep 30, 2019 | 2,335.00 |
| Jun 30, 2019 | 99.00 |
| Mar 31, 2019 | 1,461.00 |
| Dec 31, 2018 | 2,213.00 |
| Sep 30, 2018 | 5,066.00 |